Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mult Scler Relat Disord ; 35: 196-202, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31400559

RESUMO

BACKGROUND: Proper management of multiple sclerosis (MS) requires feedback from clinical practice via registries. OBJECTIVE: To introduce the Czech national multiple sclerosis registry, ReMuS, and explore the availability and use of disease-modifying drugs (DMD). METHODS: The analysis focused on patients who started their first DMD, either with first-line or second-line medication and was based on reimbursement criteria set by Czech regulators. Baseline information was used to predict relapses after DMD initiation and to compare patients that started DMD in different years. RESULTS: A total of 3,328 patients started DMD treatment for MS between 2013 and 2016; 3,203 on first-line and 125 on second-line medication. The proportion of patients starting on second-line drugs increased from 1.8% in 2013 to 4.7% in 2016. The occurrence of a relapse within one year of DMD initiation was significantly related to (1) the Expanded Disability Status Scale (EDSS) score immediately prior to starting DMD and (2) the number of previous relapses. Both parameters were significantly lower in patients starting in later years of the explored interval. CONCLUSION: Data from the ReMuS registry highlights improvements made in the management of MS in the Czech Republic. However, a relatively low percentage of patients started treatment using second-line drugs, in contrast to trends in other countries.


Assuntos
Fatores Imunológicos/uso terapêutico , Esclerose Múltipla/tratamento farmacológico , Adulto , República Tcheca , Progressão da Doença , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Recidiva , Sistema de Registros , Resultado do Tratamento , Adulto Jovem
2.
Physiol Res ; 49(3): 339-45, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11043921

RESUMO

The day-night variation of food intake and alkaline phosphatase (AP) activity was studied in the duodenum of rats neonatally treated with monosodium glutamate (MSG) and saline-treated (control) rats. The animals were kept under light-dark conditions (light phase from 09:00 h to 21:00 h) with free access to food. AP activity was cytophotometrically analyzed in the brush-border of enterocytes separated from the tip, middle and cryptal part of the villi every 6 h over a 24-hour period. In comparison with the controls, MSG-treated rats consumed about 40% less food during the dark period and their 24-hour food intake was thus significantly lowered (P<0.001). On the other hand, the nocturnal feeding habit showed a similar pattern: food consumption was high during the night (65% vs. 75%) and the lowest consumption was found during the light phase (35% vs. 25%) in MSG-treated and control rats, respectively. In agreement with the rhythm of food intake, the highest AP activity was observed during the dark phase and was lowest during the light phase in both groups of animals. These significant day-night variations showed nearly the same pattern in the enterocytes of all observed parts along the villus axis. In comparison with the controls, a permanent increase of AP activity was observed in neonatal MSG-treated rats. This increase was more expressive during the dark phase of the day in the cryptal (P<0.001) and middle part of the villus (P<0.01). From the viewpoint of feeding, this enzyme in MSG-treated rats was enhanced in an inverse relation to the amount of food eaten i.e. despite sustained hypophagia the mean AP activity in the enterocytes along the villus axis was higher than in the control animals during all investigated periods. The present results suggest that the increased AP activity in MSG-treated rats is probably not a consequence of actual day-night eating perturbations but could be a component of a more general effect of MSG. This information contributes to better understanding of the function of intestinal AP and its relation to day-night feeding changes especially in connection with the MSG syndrome.


Assuntos
Fosfatase Alcalina/metabolismo , Ritmo Circadiano/fisiologia , Aditivos Alimentares/farmacologia , Glutamato de Sódio/farmacologia , Animais , Animais Recém-Nascidos , Escuridão , Duodeno/citologia , Duodeno/enzimologia , Ingestão de Alimentos/fisiologia , Enterócitos/efeitos dos fármacos , Enterócitos/enzimologia , Ativação Enzimática/efeitos dos fármacos , Ativação Enzimática/fisiologia , Absorção Intestinal/efeitos dos fármacos , Absorção Intestinal/fisiologia , Iluminação , Masculino , Microvilosidades/enzimologia , Obesidade/metabolismo , Ratos , Ratos Wistar
3.
Physiol Res ; 49(2): 269-77, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10984094

RESUMO

In the present work neonatal male and female Wistar rats were treated intraperitoneally with monosodium glutamate (MSG 2 mg/kg b.w.) or saline (controls) daily for 4 day after birth. At the age of 30 and 80 days, the alkaline phosphatase activity (AP) in the brush border of individual enterocytes, the body fat content and Lee's index of obesity were analyzed. Microdensitometrical quantification of AP was significantly increased on day 30 in males (P<0.01) and on day 80 in MSG-treated male and female rats (P<0.001) as compared to the controls. MSG administration also increased the body fat weight and the obesity index significantly (P<0.001) in 80-day-old animals, but was without any significant effect on their food intake. Our results showed that a) neonatal MSG-treatment may significantly change the intestinal function and b) the investigation of the intestinal enzyme activities may be important in further studies on MSG-induced and other forms of obesity.


Assuntos
Fosfatase Alcalina/metabolismo , Duodeno/enzimologia , Enterócitos/enzimologia , Glutamato de Sódio/farmacologia , Tecido Adiposo/patologia , Envelhecimento/metabolismo , Animais , Animais Recém-Nascidos/crescimento & desenvolvimento , Animais Recém-Nascidos/metabolismo , Duodeno/citologia , Duodeno/efeitos dos fármacos , Feminino , Injeções Intraperitoneais , Masculino , Obesidade/induzido quimicamente , Obesidade/patologia , Tamanho do Órgão/efeitos dos fármacos , Ratos , Ratos Wistar , Valores de Referência , Distribuição Tecidual
4.
Histochem J ; 30(8): 583-9, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9792277

RESUMO

A simple separation method enabling the quantification of alkaline phosphatase activity in unfixed, isolated, individual, duodenal epithelial cells has been presented. The activity of intestinal brush border-bound alkaline phosphatase has been demonstrated using naphthol AS-BI phosphate as a substrate and hexazotized New Fuchsin as a simultaneous coupling agent. The amount of final reaction product, as measured cytophotometrically, increases linearly with incubation time (up to 10 min) and with substrate concentration (up to 0.4 mM). Maximum enzyme activity was obtained at pH 8.9. Variation of the substrate concentration revealed the kinetic parameters for naphthol AS-BI phosphate as Km = 0.17 i 0.015 and Vmax = 13.9 +/- 1.38. The specificity of the enzyme reaction was confirmed by the complete inhibition of the enzyme activity in the presence of L-cysteine (10 mm) and 80% inhibition with L-phenylalanine (30 mM). Comparison of alkaline phosphatase activity in 8-microm cryostat sections (beginning at the tip and proceeding to the cryptal part) along the villus axis, with the activity of individual cells obtained by successive separation, revealed similar values of the percentage quotient derived from the entire activities in these two different methods. This suggests that the presented separation procedure gives rise to isolation of the respective cells from the corresponding areas of the villus. Finally, the isolated cells can be used as a valuable tool for the quantitative analysis of alkaline phosphatase activity along the length of the villus.


Assuntos
Fosfatase Alcalina/metabolismo , Duodeno/enzimologia , Histocitoquímica/métodos , Mucosa Intestinal/enzimologia , Fosfatase Alcalina/antagonistas & inibidores , Animais , Separação Celular , Cisteína/farmacologia , Densitometria , Duodeno/citologia , Inibidores Enzimáticos/farmacologia , Secções Congeladas , Concentração de Íons de Hidrogênio , Mucosa Intestinal/citologia , Masculino , Microvilosidades/enzimologia , Fenilalanina/farmacologia , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...